{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+eligibility+monitoring", "query": { "intervention": "Standard eligibility monitoring" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 58, "total_pages": 6, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Standard+eligibility+monitoring&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-10T20:10:45.734Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04813627", "title": "Epidemiological Study to Monitor Study Participants With Resected Stage II (High Risk) or Stage III Colorectal Cancer for Circulating Tumor DNA Before, During and After Their Treatment With Adjuvant Chemotherapy", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Colorectal Cancer Stage II", "Colorectal Cancer Stage III" ], "interventions": [ { "name": "Regular blood sample collection for ctDNA assessment", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "BioNTech SE", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2079, "start_date": "2021-07-02", "completion_date": "2026-04-23", "has_results": false, "last_update_posted_date": "2026-05-22", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 17, "location_summary": "California City, California • Concord, California • Greenbrae, California + 14 more", "locations": [ { "city": "California City", "state": "California" }, { "city": "Concord", "state": "California" }, { "city": "Greenbrae", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT04813627" }, { "nct_id": "NCT02704052", "title": "Real-time Anti-Factor Xa Measurements in Surgical Patients to Examine Enoxaparin Metabolism and Optimize Enoxaparin Dose", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Deep Venous Thrombosis", "Pulmonary Embolus", "Venous Thromboembolism" ], "interventions": [ { "name": "Real time enoxaparin dose adjustment", "type": "DRUG" }, { "name": "Standard enoxaparin dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 116, "start_date": "2016-03", "completion_date": "2018-10", "has_results": false, "last_update_posted_date": "2019-05-24", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02704052" }, { "nct_id": "NCT04727567", "title": "Evaluation of a Personalized Care Management Program for High Hospital Utilizers", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Comorbidities and Coexisting Conditions" ], "interventions": [], "intervention_types": [], "sponsor": "Wake Forest University Health Sciences", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 454, "start_date": "2020-04-23", "completion_date": "2021-08-31", "has_results": false, "last_update_posted_date": "2022-04-22", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Charlotte, North Carolina", "locations": [ { "city": "Charlotte", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04727567" }, { "nct_id": "NCT07768215", "title": "Miniature In-line Respirator", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Brain Death", "Respiration, Artificial" ], "interventions": [ { "name": "Hope inVent", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "National Institutes of Health Clinical Center (CC)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "100 Years", "sex": "ALL", "summary": "1 Year to 100 Years" }, "enrollment_count": 5, "start_date": "2026-09-15", "completion_date": "2028-12-01", "has_results": false, "last_update_posted_date": "2026-09-10", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT07768215" }, { "nct_id": "NCT02970032", "title": "Evaluation of Anti-Xa Levels in Surgery Patients Receiving Fixed Dose Heparin", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Deep-Venous Thrombosis", "Pulmonary Embolism", "Venous Thromboembolism" ], "interventions": [ { "name": "Real time heparin dose adjustment", "type": "DRUG" }, { "name": "Standard heparin dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Utah", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 20, "start_date": "2016-11-10", "completion_date": "2017-12-08", "has_results": true, "last_update_posted_date": "2019-07-24", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02970032" }, { "nct_id": "NCT05426928", "title": "Thermodynamic Model of Hyperthermia in Humans Undergoing HIPEC", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "HIPEC" ], "interventions": [ { "name": "Additional temperature monitoring/recording", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Henry Ford Health System", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2022-09-22", "completion_date": "2027-03-31", "has_results": false, "last_update_posted_date": "2025-10-20", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Detroit, Michigan", "locations": [ { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05426928" }, { "nct_id": "NCT03971734", "title": "Determining Dose of Regadenoson Most Likely to Transiently Alter the Integrity of the Blood-Brain Barrier in Patients With High Grade Gliomas", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "High Grade Glioma", "Anaplastic Astrocytoma", "Anaplastic Oligodendroglioma", "Glioblastoma" ], "interventions": [ { "name": "Regadenoson 0.05mg", "type": "DRUG" }, { "name": "Regadensoson 0.1mg", "type": "DRUG" }, { "name": "Regadensoson 0.2mg", "type": "DRUG" }, { "name": "Regadensoson 0.4mg", "type": "DRUG" }, { "name": "Regadensoson 0.7mg", "type": "DRUG" }, { "name": "Regadensoson 1.0mg", "type": "DRUG" }, { "name": "Regadensoson 1.4mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 7, "start_date": "2019-12-06", "completion_date": "2023-10-02", "has_results": false, "last_update_posted_date": "2023-10-06", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Winston-Salem, North Carolina", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Winston-Salem", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03971734" }, { "nct_id": "NCT04089202", "title": "Diabetes eConsult Non-Inferiority Study", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetes" ], "interventions": [ { "name": "eConsult", "type": "OTHER" }, { "name": "Standard of care", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Boston Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 87, "start_date": "2020-02-03", "completion_date": "2022-09-27", "has_results": false, "last_update_posted_date": "2023-02-24", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04089202" }, { "nct_id": "NCT03628989", "title": "Technology-Based Distractions During Minor Procedures", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pain", "Anxiety", "Procedural Anxiety" ], "interventions": [ { "name": "Use of Virtual Technology", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Stanford University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": "17 Years", "sex": "ALL", "summary": "Up to 17 Years" }, "enrollment_count": 58, "start_date": "2018-06-01", "completion_date": "2023-07-11", "has_results": false, "last_update_posted_date": "2023-09-28", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Palo Alto, California", "locations": [ { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03628989" }, { "nct_id": "NCT01825278", "title": "Evaluation of a Respiratory Monitor in Surgical Patients With a BMI>35", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Obesity", "Obstructive Sleep Apnea" ], "interventions": [ { "name": "ExSpiron Respiratory Volume Monitor (RVM, ExSpiron™, Respiratory Motion, Inc.; Waltham, MA", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Tufts Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 90, "start_date": "2013-02", "completion_date": "2024-04-30", "has_results": false, "last_update_posted_date": "2024-05-03", "last_synced_at": "2026-09-10T20:10:45.734Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01825278" } ] }